chr11-102138549-A-G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001130145.3(YAP1):c.573-23907A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0426 in 152,326 control chromosomes in the GnomAD database, including 215 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.043   (  215   hom.,  cov: 32) 
Consequence
 YAP1
NM_001130145.3 intron
NM_001130145.3 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -0.0940  
Publications
8 publications found 
Genes affected
 YAP1  (HGNC:16262):  (Yes1 associated transcriptional regulator) This gene encodes a downstream nuclear effector of the Hippo signaling pathway which is involved in development, growth, repair, and homeostasis. This gene is known to play a role in the development and progression of multiple cancers as a transcriptional regulator of this signaling pathway and may function as a potential target for cancer treatment. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2013] 
YAP1 Gene-Disease associations (from GenCC):
- uveal coloboma-cleft lip and palate-intellectual disabilityInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P, Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91). 
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.114  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0427  AC: 6497AN: 152208Hom.:  217  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
6497
AN: 
152208
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.0426  AC: 6491AN: 152326Hom.:  215  Cov.: 32 AF XY:  0.0451  AC XY: 3356AN XY: 74478 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
6491
AN: 
152326
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
3356
AN XY: 
74478
show subpopulations 
African (AFR) 
 AF: 
AC: 
440
AN: 
41568
American (AMR) 
 AF: 
AC: 
1818
AN: 
15310
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
89
AN: 
3468
East Asian (EAS) 
 AF: 
AC: 
320
AN: 
5178
South Asian (SAS) 
 AF: 
AC: 
140
AN: 
4830
European-Finnish (FIN) 
 AF: 
AC: 
573
AN: 
10614
Middle Eastern (MID) 
 AF: 
AC: 
11
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
3005
AN: 
68036
Other (OTH) 
 AF: 
AC: 
84
AN: 
2116
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.502 
Heterozygous variant carriers
 0 
 324 
 647 
 971 
 1294 
 1618 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 70 
 140 
 210 
 280 
 350 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
127
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.